Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alcohols from Carbonyl Compounds: Reduction02:23

Alcohols from Carbonyl Compounds: Reduction

Reduction is a simple strategy to convert a carbonyl group to a hydroxyl group. The three major pathways to reduce carbonyls to alcohols are catalytic hydrogenation, hydride reduction, and borane reduction.
Catalytic hydrogenation is similar to the reduction of an alkene or alkyne by adding H2 across the pi bond in the presence of transition metal catalysts like Raney Ni, Pd–C, Pt, or Ru. Aldehydes and ketones can be reduced by this method, often under mild to moderate heat (25–100°C) and...
Protecting Groups for Aldehydes and Ketones: Introduction01:23

Protecting Groups for Aldehydes and Ketones: Introduction

Protecting groups are compounds that can bind to a specific functional group in the presence of other functional groups to protect them from undesired chemical reactions. These compounds can selectively bind to particular functional groups and advance chemoselective reactions in polyfunctional systems (Figure 1). After the functional group has served its purpose, it is removed by reacting it with specific compounds.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of precursor origins of synthetic graphite anodes in lithium-ion batteries using LDI-MS and multivariate analysis.

Nano convergence·2026
Same author

Self-Healing and Joule Heating of Electrically Conductive CNT/BIIR Composite Films.

ACS omega·2026
Same author

Nickel Single-Atom Nanozyme for Multimodal Cancer Therapy.

ACS applied materials & interfaces·2026
Same author

Modulation of Peptoid Nanostructure for Antibiofilm Hydrogel Interfaces.

Nano letters·2026
Same author

Graphene oxide-based fluorescent biosensor for high-throughput screening to discover SARS-CoV-2 RdRp inhibitors.

Journal of materials chemistry. B·2026
Same author

Glioblastoma Immunotherapy Adjuvants for Glial Cell Polarization Regulation.

Experimental neurobiology·2025

Related Experiment Video

Updated: Jun 4, 2026

Scalable Syntheses of Graphene Oxide and Reduced Graphene Oxide using Cascade Design Oxidation and Highly Basic Reduction Reactions
08:57

Scalable Syntheses of Graphene Oxide and Reduced Graphene Oxide using Cascade Design Oxidation and Highly Basic Reduction Reactions

Published on: July 3, 2025

Biocompatible reduced graphene oxide prepared by using dextran as a multifunctional reducing agent.

Young-Kwan Kim1, Mi-Hee Kim, Dal-Hee Min

  • 1Department of Chemistry, Institute for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), 373-1 Guseong-dong, Yuseong-gu, Daejeon 305-701, Korea.

Chemical Communications (Cambridge, England)
|February 3, 2011
PubMed
Summary

A new method uses dextran to create biocompatible reduced graphene oxide (RGO) efficiently and affordably. This dextran-coated RGO is water-soluble and safe for biological applications.

More Related Videos

Visible-light Induced Reduction of Graphene Oxide Using Plasmonic Nanoparticle
07:24

Visible-light Induced Reduction of Graphene Oxide Using Plasmonic Nanoparticle

Published on: September 22, 2015

Graphene Coatings for Biomedical Implants
13:21

Graphene Coatings for Biomedical Implants

Published on: March 1, 2013

Related Experiment Videos

Last Updated: Jun 4, 2026

Scalable Syntheses of Graphene Oxide and Reduced Graphene Oxide using Cascade Design Oxidation and Highly Basic Reduction Reactions
08:57

Scalable Syntheses of Graphene Oxide and Reduced Graphene Oxide using Cascade Design Oxidation and Highly Basic Reduction Reactions

Published on: July 3, 2025

Visible-light Induced Reduction of Graphene Oxide Using Plasmonic Nanoparticle
07:24

Visible-light Induced Reduction of Graphene Oxide Using Plasmonic Nanoparticle

Published on: September 22, 2015

Graphene Coatings for Biomedical Implants
13:21

Graphene Coatings for Biomedical Implants

Published on: March 1, 2013

Area of Science:

  • Materials Science
  • Nanotechnology
  • Biomedical Engineering

Background:

  • Reduced graphene oxide (RGO) possesses unique properties but often requires complex synthesis methods.
  • Developing cost-effective and environmentally friendly production of RGO is crucial for its widespread application.
  • Biocompatibility and water solubility are key challenges for RGO in biological systems.

Purpose of the Study:

  • To develop a large-scale, cost-effective, and environmentally friendly synthetic strategy for biocompatible reduced graphene oxide (RGO).
  • To utilize dextran as a dual-function agent for both reduction and stabilization of graphene oxide.
  • To evaluate the water solubility and biocompatibility of the resulting dextran-coated RGO (D-RGO).

Main Methods:

  • A novel synthesis approach employing dextran as a reducing and stabilizing agent for graphene oxide.
  • Characterization of the synthesized material to confirm the formation of reduced graphene oxide.
  • Assessment of the solubility of the dextran-coated RGO in aqueous solutions.
  • Evaluation of the biocompatibility of the D-RGO using relevant assays.

Main Results:

  • Successful development of a large-scale synthetic strategy for RGO.
  • Demonstration of dextran's efficacy as both a reducing and stabilizing agent.
  • Achieved high water solubility for the dextran-coated RGO (D-RGO).
  • Confirmed high biocompatibility of the synthesized D-RGO.

Conclusions:

  • A scalable, economical, and green synthesis for biocompatible RGO has been established.
  • Dextran effectively facilitates the reduction and stabilization of graphene oxide, yielding water-soluble D-RGO.
  • The developed D-RGO exhibits excellent biocompatibility, making it suitable for various biomedical applications.